Kayne Anderson Rudnick Investment Management
TNDM icon

Kayne Anderson Rudnick Investment Management’s Tandem Diabetes Care TNDM Stock Holding History

Kayne Anderson Rudnick Investment Management’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-7
Closed -$1K – 683
2022
Q1 		$1K Buy
+7
New +$817 ﹤0.01% 647
2021
Q1 		– Sell
-3
Closed – – 717
2020
Q4 		$0 Buy
+3
New +$309 ﹤0.01% 727

Other funds holding TNDM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management's TNDM Position: Q2 2022 in Review

Kayne Anderson Rudnick Investment Management sold out of Tandem Diabetes Care (TNDM) in Q2 2022, closing a stake of 7 shares — an estimated $1K sold.

Kayne Anderson Rudnick Investment Management first reported a position in TNDM in Q4 2020 and held it in 2 quarters. The position peaked at $1K in Q1 2022. 330 funds tracked by Wall St. Rank hold TNDM as of Q2 2022.

  • Kayne Anderson Rudnick Investment Management reported no remaining Tandem Diabetes Care position as of Q2 2022 after selling out during the quarter.
  • Kayne Anderson Rudnick Investment Management sold 7 Tandem Diabetes Care shares in Q2 2022, an estimated $1K.
  • Kayne Anderson Rudnick Investment Management first reported a position in Tandem Diabetes Care in Q4 2020 and held it in 2 quarters.
  • Kayne Anderson Rudnick Investment Management's Tandem Diabetes Care position peaked at $1K in Q1 2022.
  • 330 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2022.

Based on Kayne Anderson Rudnick Investment Management's 13F filing for Q2 2022, filed 12 Aug 2022.